ITO Takanori 伊藤隆徳

Researcher Number	00827389
Other IDs
Affiliation (Current)	2025: 名古屋大学, 医学部附属病院, 助教
Affiliation (based on the past Project Information) *help	2025: 名古屋大学, 医学部附属病院, 助教 2023: 名古屋大学, 医学部附属病院, 助教 2019 – 2022: 名古屋大学, 医学部附属病院, 病院助教
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related / Basic Section 47040:Pharmacology-related
Keywords	Principal Investigator irAE / 免疫チェックポイント阻害薬 / マクロファージ / 肝細胞癌 / HCC / 肝障害 / 硬化性胆管炎 / 薬物性肝障害 / 腸管相関 / 線維化 … More / 肝再生 / 幹細胞 / 星細胞 / 肝硬変 / 歯髄幹細胞 / 抗線維化 / 腸管透過性 / 脂肪肝 / 腸肝相関 / ヒト乳歯歯髄幹細胞 / SHED-CM / NASH Less

免疫動態の変化に着目したICIによる肝障害に対する効果的な治療ストラテジーの構築Principal Investigator
- Principal Investigator
  
  伊藤隆徳
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47040:Pharmacology-related
- Research Institution
  Nagoya University
肝内マクロファージ極性と類洞内皮障害に着目したirAE肝障害の発症機序の解明Principal Investigator
- Principal Investigator
  
  伊藤隆徳
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nagoya University
Development of a novel therapy for NASH focusing on the intestinal-liver organ correlation produced by factors form dental pulp stem cellPrincipal Investigator
- Principal Investigator
  
  ITO Takanori
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nagoya University

All 2024 2023 2022 2021 2020

All Journal Article Presentation Book

[Book] 月刊『腫瘍内科』第32巻第1号（2023年7月）特集/免疫チェックポイント阻害薬：State of the artにおける位置づけと今後の方向性 3.　肝臓がん Hepatocellular Carcinoma2023
- Author(s)
  伊藤　隆徳、山本　崇文、水野　和幸、石上　雅敏、川嶋　啓揮
- Total Pages
  7
- Publisher
  科学評論社
- Data Source
  KAKENHI-PROJECT-22K15962
[Journal Article] Outcomes of immune checkpoint inhibitor‐induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team2024
- Author(s)
  Ito Takanori、Mizuno Kazuyuki、Yamamoto Takafumi、Yasuda Tsukasa、Yokoyama Shinya、Yamamoto Kenta、Imai Norihiro、Ishizu Yoji、Honda Takashi、Hama Masayo、Kataoka Tomomi、Shimokata Tomoya、Ando Yuichi、Kawashima Hiroki
- Journal Title
  
  Hepatology Research
  
  Volume: - Issue: 11 Pages: 1060-1069
- DOI
  10.1111/hepr.14043
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K15962
[Journal Article] 特集肝疾患-診療のチェックポイント2023 第Ⅰ部　診断のチェックポイント　第5章　肝疾患鑑別診断のチェックポイント　1.薬物性肝障害が疑われるとき2023
- Author(s)
  伊藤隆徳、山本崇文、水野和幸、石上雅敏、川嶋啓揮
- Journal Title
  
  臨床消化器内科
  
  Volume: 38 Issue: 7 Pages: 799-806
- DOI
  10.19020/CG.0000002668
- ISSN
  0911-601X, 2433-2488
- Year and Date
  2023-06-09
- Data Source
  KAKENHI-PROJECT-22K15962
[Journal Article] Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis2023
- Author(s)
  Yamamoto Takafumi、Mizuno Kazuyuki、Ito Takanori et al.
- Journal Title
  
  Investigational New Drugs
  
  Volume: 41 Issue: 3 Pages: 512-521
- DOI
  10.1007/s10637-023-01366-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K15962
[Journal Article] Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury2023
- Author(s)
  Yamamoto T, Morooka H, Ito T（Corresponding）, Ishigami M, Mizuno K, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Yokota K, Hase T, Maeda O, Hashimoto N, Ando Y, Akiyama M, Kawashima H.
- Journal Title
  
  J Gastroenterol Hepatol.
  
  Volume: 38 Issue: 2 Pages: 251-258
- DOI
  10.1111/jgh.16038
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K15962
[Journal Article] A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis2022
- Author(s)
  Yamamoto T, Ito T（Corresponding）, Mizuno K, Shinya Y, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H, Matsui T, Hase T, Hashimoto N, Ishigami M.
- Journal Title
  
  J Dig Dis
  
  Volume: 23 Issue: 7 Pages: 404-409
- DOI
  10.1111/1751-2980.13122
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K15962
[Journal Article] Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis2021
- Author(s)
  Muto H. Ito T, Tanaka T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Maeda K, Honda T, Ishikawa T, Kato A, Ohshiro T, Kano F, Yamamoto A, Sakai K, Hibi H, Ishigami M, Fujishiro M
- Journal Title
  
  Scientific Reports
  
  Volume: 11 Issue: 1 Pages: 18778-18778
- DOI
  10.1038/s41598-021-98254-8
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19H03851, KAKENHI-PROJECT-21K10067, KAKENHI-PROJECT-19K17457, KAKENHI-PROJECT-19K18241, KAKENHI-PROJECT-21K16571
[Presentation] 「肝細胞癌薬物療法 Up To Date」2023
- Author(s)
  伊藤　隆徳
- Organizer
  日本消化器病学会東海支部第138回例会　中外製薬共済セミナー
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] 免疫チェックポイント阻害薬によるirAE肝障害の臨床的特徴と治療経過の検討2023
- Author(s)
  伊藤隆徳、石上雅敏、川嶋啓揮
- Organizer
  第31回JDDW　ワークショップ13-6　薬物性肝障害の診断基準改訂を目指して
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] irAEミニレクチャー　肝機能障害2023
- Author(s)
  伊藤　隆徳
- Organizer
  日本臨床腫瘍学会　がん免疫薬物療法マネジメントセミナーアドバンスコース (Web)
- Invited
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis2023
- Author(s)
  Takanori Ito, Takafumi Yamamoto, Kazuyuki Mizuno, Shinya Yokoyama, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Satoshi Yasuda, Hidenori Toyoda, Hiroki Kawashima
- Organizer
  APASL Oncology 2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] Managing the Adverse Events of Combination Therapy with Atezolizumab and Bevacizumab to Improve Prognosis in Patients with Unresectable Hepatocellular Carcinoma2023
- Author(s)
  Takanori Ito
- Organizer
  第33回アジア太平洋肝臓学会年次総会
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] 当院のチーム医療としての免疫関連肝障害の対策　重症irAE肝障害の早期発見・治療のために2023
- Author(s)
  伊藤　隆徳、石上　雅敏、川嶋　啓揮
- Organizer
  第109回　日本消化器病学会総会　ワークショップ6 免疫チェックポイント阻害剤による消化器系臓器障害
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] Clinical features and outcomes of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies2023
- Author(s)
  Takanori Ito, Takafumi Yamamoto, Kazuyuki Mizuno, Shinya Yokoyama, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Satoshi Yasuda, Hidenori Toyoda, Masatoshi Ishigami, Hiroki Kawashima
- Organizer
  The Liver Meeting 2023 (AASLD)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] Outcomes of immune-related liver injury managed by hepatologists in a multidisciplinary toxicity team2023
- Author(s)
  Takanori Ito, Kazuyuki Mizuno, Takafumi Yamamoto, Masayo Hama, Tomomi Kataoka, Tomoya Shimokata, Hiroki Kawashima, Yuichi Ando
- Organizer
  JSMO 2024 13．多職種連携プログラム 13-01．チーム医療
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] 血清オステオポンチン値は肝細胞癌に対するAtezolizumab+Bevacizumab療法の抗腫瘍効果予測マーカーである2023
- Author(s)
  伊藤隆徳、由雄祥代、豊田秀徳
- Organizer
  第59回日本肝癌研究会　シンポジウム3
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] 乳歯歯髄幹細胞培養上清を用いたNASH/NAFLD治療の可能性2022
- Author(s)
  武藤　久哲，伊藤　隆徳，石上　雅敏
- Organizer
  第４４回日本肝臓学会東部会　パネルディスカッション４肝再生・移植医療への新規トランスレーショナルリサーチ
- Data Source
  KAKENHI-PROJECT-19K17457
[Presentation] 免疫チェックポイント阻害薬に起因する免疫関連硬化性胆管炎の臨床的特徴2022
- Author(s)
  伊藤　隆徳、川嶋　啓揮、石上　雅敏
- Organizer
  日本消化器病学会東海支部第136回例会　シンポジウム
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] irAE消化器障害の早期診断・ ICI治療継続のポイント（肝障害を中心に）2022
- Author(s)
  伊藤　隆徳
- Organizer
  JDDW2022FUKUOKA　サテライトシンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] 免疫チェックポイント阻害薬によるirAE肝障害の早期診断・適正治療のためのストラテジー2022
- Author(s)
  伊藤　隆徳
- Organizer
  第63回日本肺癌学会学術集会　ワークショップ
- Invited
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] irAE肝障害におけるステロイド非投与改善例の臨床的特徴と免疫チェックポイント阻害薬再投与後経過の検討2022
- Author(s)
  伊藤　隆徳、豊田　秀徳、石上　雅敏
- Organizer
  第58回日本肝臓学会総会　口演
- Data Source
  KAKENHI-PROJECT-22K15962
[Presentation] Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis2021
- Author(s)
  Hisanori Muto, Takanori Ito, Masatoshi Ishigami
- Organizer
  AASLD（アメリカ肝臓学会）2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17457
[Presentation] NASH線維化マウスモデルに対する歯髄幹細胞無血清培養上清の病態改善効果作用の検討2021
- Author(s)
  武藤久哲、伊藤隆徳、石上雅敏
- Organizer
  肝臓学会総会 2021
- Data Source
  KAKENHI-PROJECT-19K17457
[Presentation] マウスNASHモデルに対する歯髄幹細胞無血清培養上清の抗線維化作用の検討2020
- Author(s)
  武藤久哲　伊藤隆徳　石上雅敏　藤城光弘
- Organizer
  第41回日本炎症再生医学会
- Data Source
  KAKENHI-PROJECT-19K17457

1. 由雄祥代 (10774060)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. HIBI Hideharu

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 酒井陽

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

ITO Takanori 伊藤 隆徳

Research Projects

Research Products

Co-Researchers

免疫動態の変化に着目したICIによる肝障害に対する効果的な治療ストラテジーの構築Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

肝内マクロファージ極性と類洞内皮障害に着目したirAE肝障害の発症機序の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a novel therapy for NASH focusing on the intestinal-liver organ correlation produced by factors form dental pulp stem cellPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Book] 月刊『腫瘍内科』第32巻第1号（2023年7月） 特集/免疫チェックポイント阻害薬：State of the artにおける位置づけと今後の方向性 3. 肝臓がん Hepatocellular Carcinoma2023

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Outcomes of immune checkpoint inhibitor‐induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 特集 肝疾患-診療のチェックポイント2023 第Ⅰ部 診断のチェックポイント 第5章 肝疾患鑑別診断のチェックポイント 1.薬物性肝障害が疑われるとき2023

Author(s)

Journal Title

DOI

ISSN

Year and Date

Data Source

[Journal Article] Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] 「肝細胞癌薬物療法 Up To Date」2023

Author(s)

Organizer

Data Source

[Presentation] 免疫チェックポイント阻害薬によるirAE肝障害の 臨床的特徴と治療経過の検討2023

Author(s)

Organizer

Data Source

[Presentation] irAEミニレクチャー 肝機能障害2023

Author(s)

Organizer

Data Source

[Presentation] Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis2023

Author(s)

Organizer

Data Source

[Presentation] Managing the Adverse Events of Combination Therapy with Atezolizumab and Bevacizumab to Improve Prognosis in Patients with Unresectable Hepatocellular Carcinoma2023

Author(s)

Organizer

Data Source

[Presentation] 当院のチーム医療としての免疫関連肝障害の対策 重症irAE肝障害の早期発見・治療のために2023

ITO Takanori 伊藤隆徳

[Book] 月刊『腫瘍内科』第32巻第1号（2023年7月）特集/免疫チェックポイント阻害薬：State of the artにおける位置づけと今後の方向性 3.　肝臓がん Hepatocellular Carcinoma2023

[Journal Article] 特集肝疾患-診療のチェックポイント2023 第Ⅰ部　診断のチェックポイント　第5章　肝疾患鑑別診断のチェックポイント　1.薬物性肝障害が疑われるとき2023

[Presentation] 免疫チェックポイント阻害薬によるirAE肝障害の臨床的特徴と治療経過の検討2023

[Presentation] irAEミニレクチャー　肝機能障害2023

[Presentation] 当院のチーム医療としての免疫関連肝障害の対策　重症irAE肝障害の早期発見・治療のために2023

[Presentation] 血清オステオポンチン値は肝細胞癌に対するAtezolizumab+Bevacizumab療法の抗腫瘍効果予測マーカーである2023

[Presentation] 免疫チェックポイント阻害薬に起因する免疫関連硬化性胆管炎の臨床的特徴2022

[Presentation] 免疫チェックポイント阻害薬によるirAE肝障害の早期診断・適正治療のためのストラテジー2022

[Presentation] irAE肝障害におけるステロイド非投与改善例の臨床的特徴と免疫チェックポイント阻害薬再投与後経過の検討2022